Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK Considers US -Style Payment Reporting Obligations For Drug And Device Firms

Executive Summary

The UK pharmaceutical industry association, the ABPI, would like to see its own system strengthened to improve reporting of payments to health care professionals and organizations.

You may also be interested in...



Top Ortho Firms Paid $516M To Physicians In 2022, Open Payments Data Shows

Analysis of Open Payments data compiled by CMS shows that Medtronic, Smith + Nephew, DePuy Synthes, Zimmer Biomet and Stryker paid a total of $516m to physicians in 2022. Top spending categories: Royalties, acquisitions and consulting fees.

Companies Need EU Funding To Cover ‘Enormous Expenditure’ Of Complying With Revised GMP Rules

Important updates to good manufacturing practice guidelines are likely to mean medicine shortages, warns a German pharmaceutical industry group.

IGBA Welcomes Mexican Membership

The IGBA has welcomed Mexican pharmaceutical industry association ANAFAM as an associate member.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT148255

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel